Investing.com - Viking Therapeutics Inc (NASDAQ: VKTX) reported third quarter EPS of $-0.230, $0.01 worse than the analyst estimate of $-0.220. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
Viking Therapeutics Inc's stock price closed at $10.670. It is down -26.110% in the last 3 months and up 157.110% in the last 12 months.
Viking Therapeutics Inc saw 1 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Viking Therapeutics Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Viking Therapeutics Inc's Financial Health score is "fair performance".
Check out Viking Therapeutics Inc's recent earnings performance, and Viking Therapeutics Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar